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SummAry – Antimüllerian hormone (Amh) is produced by Sertolli cells of the testes and 
granulosa cells of the ovaries. recent studies have indicated that Amh may be a novel measure of 
ovarian reserve. Also, earlier reports have presented minimal fluctuations of Amh levels througho-
ut the menstrual cycle. The aim of this preliminary study was to demonstrate the relation of serum 
Amh levels and age in women with regular menstrual cycles and normal hormonal regulation of 
ovarian function. The study included 35 women divided into two groups of women aged 30 or yo-
unger and those older than 30. hormone concentrations were assessed by measurements of lutropin 
(lh), follitropin (fSh), estradiol (e2), testosterone (t), sex hormone binding globulin (ShBg) 
and Amh on cycle day 3-5 (follicular phase); and lh, fSh and e2 on cycle day 13-15 (ovulation). 
Progesterone level was determined on cycle day 19-23 (luteal phase). median age differed signifi-
cantly between the two groups of study subjects (p=0.001). Study results confirmed regular ovarian 
response to physiological gonadotropin stimulation, which is the assumption for normo-ovulatory 
cycles. Some decrease in the mean serum Amh levels was recorded in women over 30 years of age, 
although the difference was not statistically significant (p=0.0693). There was no statistically signi-
ficant difference in serum Amh concentrations between follicular phase and ovulation in study 
women (p=0.3124). our preliminary results, although obtained in a limited number of women, 
support the diagnostic value of Amh as a reliable marker of ovarian reserve.
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Introduction
Antimüllerian hormone (Amh) is a glycoprotein, 
a member of the transforming growth factor-b family. 
in men, Amh is produced by Sertolli cells of testes, 
from antenatal testicular differentiation up to puberty 
and adult age1. on the other hand, it is secreted by 
granulosa cells of women’s ovaries, from puberty to 
menopause1. in prepubertal girls, serum Amh lev-
els are undetectable or very low, with maximal values 
detected after the onset of puberty2. The highest ex-
pression of Amh has been demonstrated in the stage 
of preantral and small antral follicles3. Positive cor-
relation has been established between serum Amh 
levels and antral follicle count (AfC), and inverse 
correlation with increasing age. in menopausal wom-
en, Amh concentrations significantly decline, until 
they become almost undetectable in postmenopausal 
stage4. on the other hand, subtle changes in serum 
levels of follicle-stimulating hormone (fSh) occur 
with diminishing of the ovarian reserve, while sig-
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nificant elevation is observed when menstrual cycles 
have already become irregular. Consequently, Amh 
is a very sensitive marker of ovarian reserve because it 
reflects the number of follicles, activated from the ex-
isting pool of primordial follicles5. furthermore, the 
advantage of Amh over other ovarian parameters is 
its independence of gonadotropins and stable serum 
concentrations during the menstrual cycle6-8.
on the trail of these findings, we have researched 
Amh levels in healthy females of reproductive age in 
our own population. The aim of this preliminary study 
was to demonstrate the relation of serum Amh levels 
with age in women with regular menstrual cycles and 
normal hormonal regulation of ovarian function. 
Subjects and Methods
out of 52 female volunteers, 35 women were se-
lected for the study, based on the inclusion criteria of 
age 18-45 years, regular menstrual cycles (30±2 days) 
within one year, and no hormonal therapy for at least 
three months. in addition, study subjects had no endo-
crine disorders that could interfere with ovarian func-
tion in their personal medical history. women were 
recruited from february 2009 until April 2009 and 
they all provided a written consent for inclusion in the 
study. Data collection and analyses were performed at 
laboratory of endocrinology, university Department 
of oncology and nuclear medicine, Sestre milosrd-
nice university hospital, Zagreb. 
Blood was collected by venepuncture during fol-
licular, ovulation and luteal phases of the current 
menstrual cycle. Samples were centrifuged and sera 
were stored at -20 ºC until analysis. Concentrations of 
lutropin (lh), follitropin (fSh), estradiol (e2), tes-
tosterone (t), sex hormone binding globulin (ShBg) 
and Amh were measured on cycle day 3-5 (follicular 
phase), and lh, fSh and e2 on cycle day 13-15 (ovu-
lation). Progesterone level was determined on cycle 
day 19-23 (luteal phase). we considered the cycle as 
ovulatory if the mid-cycle lh peak occurred as well 
as if the mid-luteal serum progesterone exceeded the 
concentration of 16 nmol/l10. All hormones except 
for Amh were assayed by electrochemiluminescence 
immunoassay (eCliA, roche Diagnostics gmbh) 
on elecsys 2010 analyzer. Amh concentrations were 
measured by enzyme-linked immunosorbent assay 
(eliSA, Diagnostic System laboratories, inc.).
Statistical analyses were performed using med-
Calc® statistical software (medCalc 9.3.9.0, frank 
Schoonjans, mariakerke, Belgium). The normality of 
distribution of parameters was ascertained by Kolgo-
morov-Smirnov test. Because of the small number of 
subjects, nonparametric analyses were applied; com-
parisons between groups were performed by mann-
whitney test and wilcoxon test for paired samples. 
The value of p<0.05 was considered statistically sig-
nificant.
Results
out of the initial number of 52 women, 17 were ex-
cluded for the reasons inconsistent with the selection 
criteria. in 12 women, we found subnormal mid-cycle 
estradiol concentrations and/or absence of progesterone 
peak in luteal phase. There was one case of started preg-
nancy and four cases with uncompleted blood collec-
tion in the current menstrual cycle. other 35 women 




































(570-898) – – – –
luteal phase – – – – – – 48.4±19.5(41.3-55.3)
Concentrations are expressed as mean ± SD, with 95% confidence interval (Ci); lh = lutropin; fSh = follitropin; e2 = estradiol; t = testos-
terone; ShBg = sex hormone binding globulin; P = progesterone
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had normal hormonal status and fulfilled inclusion cri-
teria. median age was 32 (range 19-44) years. 
Concentrations of measured hormones in study 
women in different phases of the cycles are shown in 
table 1. Concentrations of free testosterone were cal-
culated on the basis of total testosterone, albumin and 
ShBg, according to the previously established for-
mula10. using Kolgomorov-Smirnov test, the results 
for all analytes fitted gaussian curve, thus confirming 
compliance with normal distribution.
to estimate the relationship of Amh and age, 
women were divided into two groups of 15 women 
aged ≤30 and 20 women aged >30. median age dif-
fered significantly between the two groups (26 vs. 36; 
p<0.0001). median value of Amh was 22.6 pmol/l 
(95% Ci: 13.2-39.0) and 16.8 pmol/l (95% Ci: 7.1-
22.4), respectively, although the decrease was not sta-
tistically significant (p=0.0693). results of compari-
son between the two groups are shown in figure 1. 
we also compared e2 and fSh levels in the two 
groups of women during follicular phase using mann-
whitney test. The mean e2 concentration was 162.5 
and 178.5 pmol/l in the ≤30 and >30 age group, re-
spectively. Serum fSh levels in the two groups were 
6.4 and 7.5 iu/l, respectively. There was no statisti-
cally significant difference in the mean concentrations 
of e2 (p=0.423) and fSh (p=0.243), when the results 
in younger women were compared with those in older 
ones.
in addition, we compared serum Amh concen-
trations in 19 women during follicular and ovulato-
ry phase. median value in follicular phase was 20.1 
pmol/l (95% Ci: 14.8-27.5) and 22.2 pmol/l (95% 
Ci: 13.7-32.4) in ovulatory phase, respectively. using 
wilcoxon test for paired samples, we found no signifi-
cant difference in Amh concentrations between the 
two phases of the cycle (p=0.3124) (fig. 2).
Discussion
recent studies have indicated that Amh may be a 
novel measure of ovarian reserve1,2,4. in addition, when 
comparing Amh with other ovarian tests, it seems to 
be the best marker reflecting the oocyte/follicle pool. 
Substantially elevated serum levels of fSh are seen 
when cycles have already become irregular11. Due to 
the lack of a similar study in Croatia, our aim was to 
evaluate Amh as a parameter dependent of ovarian 
aging in a group of women in reproductive age of our 
own population. we are aware that regular menstrual 
cycle and normal serum levels of gonadotropins and 
ovarian steroid hormones are not sufficient to confirm 
the woman’s reproductive health. Therefore, we had 
no intention to correlate Amh with fertility potential 
of study women, but to find the relationship of Amh 
with other parameters relevant for the assessment of 
ovarian function. The role of Amh in predicting 
ovarian response in women with decreased fertility, 
especially before treatment in the assisted reproduc-
Fig. 1. Serum antimüllerian hormone (AMH) levels in 
women according to age (group 1: ≤30 years and group 2: 
>30 years).
Fig. 2. Comparison of serum antimüllerian hormone (AMH) 
concentrations between the follicular and ovulatory phase of 
menstrual cycle (n=19).
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tive technology (Art) procedures, has been studied 
profoundly1,5. Assuming that serum Amh concen-
tration is a sign of follicular reserve exhaustion, we 
divided study women into two groups, arbitrarily tak-
ing the age of 30 as a boundary. median age differed 
significantly between the two groups. we showed a 
certain decrease in the mean serum Amh levels in 
women over 30 years of age, although the difference 
was not statistically significant. in addition, we com-
pared their fSh and e2 levels as serum parameters 
that are physiologically associated with ovarian aging. 
in both groups of women, we confirmed regular ovar-
ian response to gonadotropin stimulation, which is 
the assumption for normoovulatory cycles. Also, me-
dian serum Amh concentrations in these women are 
in a range that reflects the preserved ovarian follicular 
pool12. As shown in a study performed by van rooij 
et al., Amh levels changed longitudinally over time 
in the same women divided into five-year classes2. of 
course, we must take into account that the number of 
35 women in our study was too small to make more 
narrow age groups and apply appropriate statistical 
analysis to get better insight in the subtle changes of 
all study hormones with aging. 
earlier reports describe minimal fluctuations of 
Amh levels throughout the menstrual cycle6-8. we 
found no statistical difference in serum Amh con-
centrations between follicular phase and ovulation 
in study women. Contrary to other ovarian reserve 
markers, the possibility of measurement of Amh at 
any time during the cycle is a great advantage in clini-
cal practice13.
in conclusion, our results, although preliminary 
and based on a limited number of women, support 
the diagnostic value of Amh as a reliable marker of 
ovarian reserve. According to the latest report of the 
Croatian institute of Public health, more than 40% 
of Croatian women get pregnant and deliver babies 
after the age of thirty14. even more, for several years 
we have also been faced with the fact that there is a 
constant decrease in the number of women that reach 
their first pregnancy in optimal period of reproductive 
life. introducing the measurement of serum Amh in 
the assessment of women’s fertility potential becomes 
one of the necessities for the novel and efficient diag-
nostic algorithm in our country as well.
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Sažetak
SerumSKe rAZine Anti-müllerovA hormonA u ŽenA S reDovitim menStruACiJSKim 
CiKluSom
I. Zec, D. Tišlarić-Medenjak, Ž. Bukovec-Megla, V. Harni i Z. Kusić
Anti-müllerov hormon (Amh) sintetizira se u Sertolijevim stanicama testisa u muškaraca i granuloza stanicama 
jajnika u žena. Dosadašnje studije dokazale su važnost određivanja anti-müllerovog hormona kao novog biljega u procjeni 
ovarijske rezerve. također, ranije objavljeni rezultati pokazali su neznačajnu promjenjivost koncentracija Amh u serumu 
tijekom menstruacijskog ciklusa. Cilj ovoga preliminarnog istraživanja bio je ustanoviti odnos koncentracije Amh u žena 
s redovitim ciklusima i normalnim hormonskim statusom u odnosu na njihovu dob. uključeno je 35 žena podijeljenih 
u skupine od 30 godina i mlađih te starijih od 30 godina. hormonsku regulaciju menstruacijskog ciklusa smo potvrdili 
određivanjem koncentracija lutropina (lh), folitropina (fSh), estradiola (e2), ukupnog i slobodnog testosterona (t), 
proteinskog nosača spolnih hormona (ShBg) te Amh u folikularnoj fazi ciklusa (3.-5. dan). u ovulacijskoj fazi (13.-15. 
dan) određivali smo koncentracije lh, fSh, e2 i Amh, odnosno progesterona (P) u luteinskoj fazi (20.-23. dan). medi-
jani dobi u mlađoj i starijoj skupini bili su statistički značajno različiti (p=0,001). rezultati su potvrdili urednu hormonsku 
regulaciju djelovanja osovine hipofiza-jajnici u izabranih ispitanica. ustanovili smo relativno niže koncentracije Amh 
u žena iznad 30 godina u usporedbi sa skupinom mlađih, iako razlika nije bila statistički značajna (p=0,0693). također, 
prosječne koncentracije Amh u folikularnoj fazi i ovulaciji nisu bile statistički značajno različite (p=0,3124). Preliminarni 
rezultati ovoga istraživanja, iako na ograničenom broju ispitanica, podupiru dijagnostičku važnost Amh kao osjetljivog 
biljega u procjeni ovarijske rezerve.
Ključne riječi: Anti-Müllerov hormon; Fertilitet – fiziologija; Jajnik – fiziologija; Menstruacijski ciklus – krv; Biološki biljezi 
- krv

